UiPath Inc. (NYSE:PATH) CFO Ashim Gupta Sells 40,000 Shares

UiPath Inc. (NYSE:PATH) CFO Ashim Gupta sold 40,000 shares of the firm’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $19.79, for a total transaction of $791,600.00. Following the sale, the chief financial officer now owns 946,848 shares of the company’s stock, valued at $18,738,121.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Ashim Gupta also recently made the following trade(s):

• On Thursday, April 4th, Ashim Gupta sold 40,000 shares of UiPath stock. The stock was sold at an average price of $21.66, for a total transaction of $866,400.00.
• On Friday, March 15th, Ashim Gupta sold 16,000 shares of UiPath stock. The shares were sold at an average price of $22.84, for a total transaction of $365,440.00.

UiPath Stock Performance

UiPath stock opened at $19.37 on Friday. UiPath Inc. has a 52 week low of $13.30 and a 52 week high of $27.87. The firm has a market capitalization of $11.02 billion, a PE ratio of -113.94 and a beta of 1.01. The business’s 50-day simple moving average is $21.44 and its 200-day simple moving average is $21.75.

UiPath (NYSE:PATH) last issued its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The company had revenue of $405.25 million for the quarter, compared to the consensus estimate of $383.32 million. Research analysts forecast that UiPath Inc. will post -0.04 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on PATH. Scotiabank lifted their price objective on UiPath from $29.00 to $30.00 and gave the company a “sector perform” rating in a research report on Thursday, March 14th. Canaccord Genuity Group lifted their price target on UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a report on Friday, March 15th. DA Davidson raised their price objective on shares of UiPath from $20.00 to $24.00 and gave the company a “neutral” rating in a research report on Thursday, March 14th. Royal Bank of Canada reissued a “sector perform” rating and issued a $29.00 target price on shares of UiPath in a research report on Monday, April 1st. Finally, Evercore ISI raised their price target on shares of UiPath from $24.00 to $27.00 and gave the company an “in-line” rating in a report on Thursday, March 14th. Nine research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, UiPath presently has an average rating of “Moderate Buy” and a consensus target price of $27.41.

Hedge Funds Weigh In On UiPath

Large investors have recently bought and sold shares of the stock. Royal London Asset Management Ltd. raised its position in shares of UiPath by 5.9% during the third quarter. Royal London Asset Management Ltd. now owns 139,544 shares of the healthcare company’s stock valued at $2,388,000 after buying an additional 7,742 shares during the last quarter. Vestmark Advisory Solutions Inc. acquired a new position in UiPath in the 4th quarter valued at approximately $15,543,000. O Shaughnessy Asset Management LLC acquired a new stake in shares of UiPath during the 3rd quarter worth approximately $203,000. Invesco Ltd. increased its position in shares of UiPath by 2.8% during the third quarter. Invesco Ltd. now owns 399,181 shares of the healthcare company’s stock valued at $6,830,000 after purchasing an additional 10,863 shares during the period. Finally, California Public Employees Retirement System raised its stake in shares of UiPath by 13.9% in the fourth quarter. California Public Employees Retirement System now owns 641,825 shares of the healthcare company’s stock valued at $15,943,000 after purchasing an additional 78,459 shares in the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.